A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- NYU Langone Health
- Enrollment
- 7630
- Locations
- 1
- Primary Endpoint
- Number of Participants Who Are CW-Compliant and CW-Noncompliant
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
This RCT will test a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module incorporates effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely (CW) guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin. The implementation of the module is triggered by patient scheduling and medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient at NYULH primary care or endocrinology practice
- •Practices that have patients aged 75 or older
- •Practices that have a diagnosis of diabetes in the EHR chart
Exclusion Criteria
- •Under age 75
Outcomes
Primary Outcomes
Number of Participants Who Are CW-Compliant and CW-Noncompliant
Time Frame: Month 18
In order to evaluate Choosing Wisely (CW) compliance status, the BE-EHR algorithm will capture information on demographics, diagnoses in the patient's problem list, prescription history, and relevant lab results (i.e. allergies and blood glucose (HbA1c)) The study team members will not collect this information directly; data will be collected in NYULH's EHR system, EPIC, and an EPIC Reporting analyst will extract the relevant parameters from the EHR into a report. The study team members only receive the ultimate determination from the algorithm that the patient is either CW-compliant or CW-noncompliant.
Secondary Outcomes
- Number of Total Prescription Encounters(Month 18)